Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001140361-22-024831
Filing Date
2022-07-01
Accepted
2022-07-01 17:13:30
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-4/A ny20004078x10_s4a.htm S-4/A 7127294
2 EXHIBIT 23.3 ny20004078x10_ex23-3.htm EX-23.3 1949
3 EXHIBIT 23.4 ny20004078x10_ex23-4.htm EX-23.4 2174
4 EXHIBIT 23.5 ny20004078x10_ex23-5.htm EX-23.5 2226
5 EXHIBIT 99.1 ny20004078x10_ex99-1.htm EX-99.1 4707
6 logo_centerviewpartnersv2.jpg GRAPHIC 20936
7 ny20003153x11_ex99-1img01.jpg GRAPHIC 67501
8 ny20003153x11_flowchart01.jpg GRAPHIC 74519
9 ny20003153x11_flowchart02.jpg GRAPHIC 119546
10 ny20003153x11_flowchart03.jpg GRAPHIC 128125
11 ny20003153x11_flowchartx1.jpg GRAPHIC 64922
12 ny20003153x11_flowchartx2.jpg GRAPHIC 104888
13 ny20003153x11_flowchartx3.jpg GRAPHIC 108201
14 ny20003153x11_piechart01.jpg GRAPHIC 62309
15 ny20003153x11_piechart02.jpg GRAPHIC 47804
  Complete submission text file 0001140361-22-024831.txt   8237824
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: S-4/A | Act: 33 | File No.: 333-263667 | Film No.: 221062320
SIC: 2835 In Vitro & In Vivo Diagnostic Substances